Morgan Stanley’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7K | Sell |
|
|||||
|
2025
Q1 | $1.42K | Buy |
|
|||||
|
2024
Q4 | $1.11K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $44 | Sell |
|
|||||
|
2024
Q1 | $35.4K | Sell |
|
|||||
|
2023
Q4 | $59.8K | Buy |
|
|||||
|
2023
Q3 | $40.2K | Sell |
|
|||||
|
2023
Q2 | $41.7K | Buy |
|
|||||
|
2023
Q1 | $42.3K | Buy |
|
|||||
|
2022
Q4 | $45.8K | Buy |
|
|||||
|
2022
Q3 | $53K | Buy |
|
|||||
|
2022
Q2 | $59K | Buy |
|
|||||
|
2022
Q1 | $20K | Buy |
|
|||||
|
2021
Q4 | $7K | Sell |
|
|||||
|
2021
Q3 | $19K | Sell |
|
|||||
|
2021
Q2 | $25K | Sell |
|
|||||
|
2021
Q1 | $47K | Sell |
|
|||||
|
2020
Q4 | $224K | Sell |
|
|||||
|
2020
Q3 | $395K | Buy |
|
|||||
|
2020
Q2 | $671K | Sell |
|
|||||
|
2020
Q1 | $439K | Buy |
|
|||||
|
2019
Q4 | $699K | Buy |
|
|||||
|
2019
Q3 | $753K | Buy |
|
|||||
|
2019
Q2 | $2.03M | Sell |
|
|||||
|
2019
Q1 | $3.27M | Sell |
|
|||||
|
2018
Q4 | $2.08M | Buy |
|
|||||
|
2018
Q3 | $656K | Buy |
|
|||||
|
2018
Q2 | $487K | Buy |
|
|||||
|
2018
Q1 | $205K | Buy |
|
|||||
|
2017
Q4 | $200K | Buy |
|
|||||
|
2017
Q3 | $75K | Buy |
|
|||||
|
2017
Q2 | $34K | Buy |
|
|||||
|
2017
Q1 | $102K | Buy |
|
|||||
|
2016
Q4 | $112K | Buy |
|
|||||
|
2016
Q3 | $73K | Buy |
|
|||||
|
2016
Q2 | $26K | Buy |
|
|||||
|
2016
Q1 | $10K | Buy |
|
|||||
|
2015
Q4 | $4K | Buy |
|
|||||
|
2015
Q3 | – | Hold |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $6K | Sell |
|
|||||
|
2014
Q4 | $53K | Buy |
|
|||||
|
2014
Q3 | $15K | Hold |
|
|||||
|
2014
Q2 | $14K | Sell |
|
|||||
|
2014
Q1 | $33K | Hold |
|
|||||
|
2013
Q4 | $46K | Buy |
|
|||||
|
2013
Q3 | $19K | Hold |
|
|||||
|
2013
Q2 | $24K | Buy |
|